ixlayer delivers a telehealth platform that simplifies the technical, user-experience, security, and regulatory components of virtual diagnostic testing. Its proprietary technology connects the health-testing ecosystem to enable rapid launch of testing programs and make lab testing accessible from patients' homes. Unlike many enterprise solutions, ixlayer says its platform can be deployed within weeks. The company targets health systems, payors, biopharma, and other health-focused organizations and can be added to existing patient engagement platforms and portals. Founded in 2018, ixlayer currently supports millions of patients and has launched hundreds of testing programs for large organizations, health systems and every level of government. Accenture’s investment is described as bolstering ixlayer’s ability to deliver scalable, flexible solutions to meet growing demand for virtual healthcare services. ixlayer provides a cloud-based technology platform that enables health systems, payors, biopharma and health-focused companies to offer diagnostic testing in a virtual environment. Its end-to-end solution addresses technical, security, regulatory and user-experience components of complex health testing and can be added to existing patient engagement platforms and portals. The platform enables real-time health and wellness lab testing through integrations with patient portals. Led by CEO Pouria Sanae, ixlayer was founded in 2018 and is based in San Francisco, California. The company currently supports more than 1 million patients, launched more than 800 testing programs in 2020 alone, and supports millions of patients across large organizations, health systems and all levels of government.

Total raised

$75M

Funding rounds

2

Latest round

Series A

Latest activity

Mar 2021